NCT02859519View on ClinicalTrials.gov

A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

PHASE3CompletedINTERVENTIONAL

Enrollment

365

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

November 13, 2019

Study Completion Date

November 13, 2019

Conditions

Distal Subungual Onychomycosis

Interventions

DRUG

MOB015B

MOB015B - Terbinafine hydrochloride (HCl) 10%, topical solution

DRUG

MOB015B Vehicle

MOB015B Vehicle without the active ingredient Terbinafine

Trial Locations (10)

Unknown

Multiple Locations

Multiple Locations

Multiple Locations

Rolling Meadows

Fridley

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Sponsors

Lead Sponsor

Moberg Pharma AB

All Listed Sponsors

lead

Moberg Pharma AB

INDUSTRY